Clinicians and scientists have conducted the most comprehensive analysis to date of pediatric high-grade glioma, making a detailed scan of the genome of 78 newly-diagnosed patients.
Researchers at the University of Helsinki and Oncos Therapeutics published results that demonstrate the anti-tumor immunity of oncolytic viruses in humans, indicating strong efficacy of the viruses against solid tumor cancers.
Research by a University of Alabama at Birmingham professor shows an association between hearing loss and the use of the erectile dysfunction drug Viagra.
Nycomed and Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration issued a complete response letter regarding the New Drug Application for Daxas.
Abbott has received Biologic License Application approval from the United States Food and Drug Administration for the ABBOTT PRISM Chagas test.
Pfizer Inc. said it will cut 6,000 jobs as it trims manufacturing capacity for health care products worldwide after acquiring smaller rival Wyeth last year.
A jury that found drug company Novartis discriminated against women by paying them less than men, promoting fewer of them and allowing a hostile workplace awarded $250 million in punitive damages.
Global efforts to control tuberculosis have failed and radical new approaches are needed say experts. With more than 9 million people infected last year, including 2 million deaths, officials say there is more tuberculosis now than at any other time in history.
The Food and Drug Administration issued a warning letter to medical device maker St. Jude Medical Inc. for promoting its device for an unapproved use.
A CRO demonstrates a new approach for an equilibrium protein binding LC-MS/MS assay.
Visual analytics provides insight into cancer vaccine clinical trials.
Made-to-order genes fill different research needs.
Biomarkers for early disease detection and therapeutic development are in high demand. However, the discovery process is hindered by several complex challenges.
New assays based on nanotechnology and stem cell science promise to reduce the need for laboratory animals while increasing the success rate of new leads.